Biotechnology/Pharmaceutical services outsourcing companies provide
their consumers with services such as auditing & assessment, consulting,
product maintenance, and regulatory affairs. Moreover, they also provide
services such as, product testing, design &validation, and training &
education, among others.
Zetasizer
to Measure Zeta Size
Reading Scientific Services Limited (RSSL) introduced Dynamic Light
Scattering (DLS) service. It recently acquired Malvern Zetasizer Nano ZSP in
their physical chemistry department.
RSSL provides particle sizing services to pharmaceutical companies.
The addition of this new equipment will allow RSSL to measure particles between
0.3nm to 10 µm (micrometre), allowing them to deliver quality service. It will
help the company deliver quality services with data integrity. Nanoparticles
are both a challenge as well as opportunity for the pharmaceutical industry.
This innovative approach it can be a potential route for drug delivery.
Nanoparticles can also play the role of potential “sponges” for toxic chemicals
in the body. They can also be a potential threat to health.
These nanoparticles can affect the performance of pharmaceutical
products such as APIs (active pharmaceutical ingredient) and excipients. The
Zetasizer will aid in the quality check (QC) and troubleshooting problems in
the research and development, where the particle size is a major concerning
factor.
The Zetasizer can measure zeta size, electrophoretic mobility of
proteins, optionally the microrheology of polymer and protein solutions, and
zeta potential of surfaces and nanoparticles. Zeta gives a quick indication
about the stability regarding the suspensions and emulsions. This determines
its potential in new formulations, aiding in early stages of long term
stability studies. It indicates protein stability, which is a very important
biopharma development.
Zetasizer can be used in a flow configuration to operate as a size
detector for field flow fraction (FFF) or size exclusion (SEC). It uses Non-Invasive Backscatter optics
(NIBS) to significantly better the performance than systems utilizing 90 degree
scattering optics.
Market
Overview
According to a new report by Grand View Research, Inc., the global biotechnology
services outsourcing market is projected to reach nearly USD
93 billion by 2025. Growing competition within the healthcare drug
manufacturers can drive the market.
Key
Players
RSSL, Lachman Associates, Quantic Group, and QuintilesIMS are major
competitor of this market. Competitors participate in mergers & acquisitions,
collaborations, regional expansions, and new product launches, to impel their
position in the market.
In-Depth
research report on biotechnology services outsourcing market:
No comments:
Post a Comment